Business Description
Fermenta Biotech Ltd
ISIN : INE225B01021
Total Employee Number:
606Description
Fermenta Biotech Ltd is engaged in the manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations, environmental solution products, and the renting and sale of properties. The Group caters to both domestic and international markets and has strategic investments in subsidiaries and associate companies mainly engaged in manufacturing and marketing bulk drugs and providing sporting, health awareness, and education services. The Group operates through the Chemicals/Bulk Drug and Property segments. The Chemicals/Bulk Drug segment, comprising chemicals, bulk drugs, and enzymes, generates maximum revenue. The Company operates in India, Europe, and other countries, with maximum revenue from India.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.73 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | 0.99 | |||||
Interest Coverage | 6.25 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.61 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.4 | |||||
3-Year FCF Growth Rate | -6.3 | |||||
3-Year Book Growth Rate | 9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.86 | |||||
Quick Ratio | 1.13 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 277.85 | |||||
Days Sales Outstanding | 74.22 | |||||
Days Payable | 131.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 26 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 1.38 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.39 | |||||
Operating Margin % | 13.42 | |||||
Net Margin % | 11.84 | |||||
EBITDA Margin % | 22.41 | |||||
ROE % | 15.65 | |||||
ROA % | 9.48 | |||||
ROIC % | 9.7 | |||||
3-Year ROIIC % | -157.35 | |||||
ROC (Joel Greenblatt) % | 24.48 | |||||
ROCE % | 22.08 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.99 | |||||
PE Ratio without NRI | 25.15 | |||||
Shiller PE Ratio | 29.26 | |||||
Price-to-Owner-Earnings | 21.09 | |||||
PS Ratio | 2.6 | |||||
PB Ratio | 3.22 | |||||
Price-to-Tangible-Book | 3.27 | |||||
Price-to-Free-Cash-Flow | 21.35 | |||||
Price-to-Operating-Cash-Flow | 14.37 | |||||
EV-to-EBIT | 14.25 | |||||
EV-to-EBITDA | 11.62 | |||||
EV-to-Revenue | 2.61 | |||||
EV-to-FCF | 21.3 | |||||
Price-to-GF-Value | 1.45 | |||||
Price-to-Projected-FCF | 2.04 | |||||
Price-to-Median-PS-Value | 1.41 | |||||
| Price-to-Net-Current-Asset-Value | 8.93 | |||||
Earnings Yield (Greenblatt) % | 7.02 | |||||
FCF Yield % | 4.78 | |||||
Forward Rate of Return (Yacktman) % | 20.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fermenta Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | |||
| EPS (TTM) (₹) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (₹) | - | ||
| 20-Day SMA (₹) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 446.05 - 460.05 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fermenta Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fermenta Biotech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fermenta Biotech Ltd Frequently Asked Questions
What is Fermenta Biotech Ltd(NSE:FERMENTA)'s stock price today?
The current price of NSE:FERMENTA is ₹456.10. The 52 week high of NSE:FERMENTA is ₹460.05 and 52 week low is ₹446.05.
When is next earnings date of Fermenta Biotech Ltd(NSE:FERMENTA)?
The next earnings date of Fermenta Biotech Ltd(NSE:FERMENTA) is .
Does Fermenta Biotech Ltd(NSE:FERMENTA) pay dividends? If so, how much?
Fermenta Biotech Ltd(NSE:FERMENTA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Fermenta Biotech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers